Insiders See AU$1.23m Investment In MedAdvisor Jump Last Week

Insiders who bought MedAdvisor Limited (ASX:MDR) stock in the last 12 months were richly rewarded last week. The company's market value increased by AU$17m as a result of the stock's 10.0% gain over the same period. Put another way, the original AU$1.23m acquisition is now worth AU$2.26m.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

See our latest analysis for MedAdvisor

MedAdvisor Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Non-Executive Director Jim Xenos bought AU$1.2m worth of shares at a price of AU$0.18 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of AU$0.33. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

MedAdvisor is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of MedAdvisor

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. From our data, it seems that MedAdvisor insiders own 6.6% of the company, worth about AU$12m. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. Whilst better than nothing, we're not overly impressed by these holdings.

So What Do The MedAdvisor Insider Transactions Indicate?

The fact that there have been no MedAdvisor insider transactions recently certainly doesn't bother us. However, our analysis of transactions over the last year is heartening. Overall we don't see anything to make us think MedAdvisor insiders are doubting the company, and they do own shares. Of course, the future is what matters most. So if you are interested in MedAdvisor, you should check out this free report on analyst forecasts for the company.

Of course MedAdvisor may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.